Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of August 4, 2026 in Grail, Inc. Lawsuit - GRAL

Grail, Inc. (GRAL) shares collapsed 50.55% on February 20, 2026, after the company disclosed that the NHS-Galleri trial failed to meet its primary endpoint for statistically significant Stage III-IV cancer reduction. A securities class action has been filed alleging that management made misleading positive representations about the trial to analysts and investors throughout the class period (May 13, 2025 - February 19, 2026), resulting in artificially inflated stock prices. The lead plaintiff deadline is August 4, 2026.